Boosting translational research in the U.K

Sci Transl Med. 2016 Sep 21;8(357):357fs15. doi: 10.1126/scitranslmed.aag1172.

¹ Department of Experimental Immunobiology, King's College London, London, U.K. National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London, U.K.
² Department of Experimental Immunobiology, King's College London, London, U.K. National Institute for Health Research Biomedical Research Centre, Guy's and St. Thomas' National Health Service Foundation Trust and King's College London, London, U.K. graham.lord@kcl.ac.uk.

Abstract

Investment in national infrastructure is critical for growth in early-phase translational research and experimental medicine.